(Pyrimidin-5-yl)boronic acid → 6-Methyl-4-pyrimidin-5-yl-pyridine-2-carboxylic acid ethyl ester
Reaktionsgleichung
[CH2:1]([O:3][C:4]([C:6]1[CH:11]=[C:10](Br)[CH:9]=[C:8]([CH3:13])[N:7]=1)=[O:5])[CH3:2].[N:14]1[CH:19]=[C:18](B(O)O)[CH:17]=[N:16][CH:15]=1>>[CH2:1]([O:3][C:4]([C:6]1[CH:11]=[C:10]([C:18]2[CH:19]=[N:14][CH:15]=[N:16][CH:17]=2)[CH:9]=[C:8]([CH3:13])[N:7]=1)=[O:5])[CH3:2]Komponenten
3
Versuchsvorschrift
The title compound, was prepared from 4-Bromo-6-methyl-pyridine-2-carboxylic acid ethyl ester (example 1, step 4) and 5-Pyrimidineboronic acid in accordance with the general method of example 1, step 6 to yield the final compound as a white solid, MS (ISP): m/e=244.3 (M+H)+.
Quellen und Nachweise
- ORD-Eintrag
- ord-61d2225a94e6419aa9616a2984d72b6c
- Quelldatensatz
- uspto-grants-2011_05
- Patentnummer
- US07951824B2
Notizen zur Reaktion
Wird geladen…